CLARAMETYX BIOSCIENCES
Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms.
CLARAMETYX BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2020-01-01
Address:
Columbus, Ohio, United States
Country:
United States
Website Url:
http://www.clarametyx.com
Total Employee:
1+
Status:
Active
Contact:
614.686.2689
Email Addresses:
[email protected]
Total Funding:
21.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - Clarametyx Biosciences
National Institute of Deafness & Communications Disorders (NIDCD)
National Institute of Deafness & Communications Disorders (NIDCD) investment in Grant - Clarametyx Biosciences
CARB-X
CARB-X investment in Grant - Clarametyx Biosciences
Official Site Inspections
http://www.clarametyx.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: 77.71.72.148.host.secureserver.net
- IP address: 148.72.71.77
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Clarametyx Biosciences"
Get To Know Us - Clarametyx Biosciences
Guided by the discoverers and inventors of this novel approach as well as expert entrepreneurial leaders, we rigorously pursue our mission to deliver a powerful new tool to combat one of the …See details»
Clarametyx Biosciences - Crunchbase Company Profile …
Organization. Clarametyx Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Clarametyx Biosciences - LinkedIn
Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections.See details»
Clarametyx Bioscience Recognized as “Infectious Disease …
Nov 19, 2024 Clarametyx has been selected to present its novel technology platform during IDWeek 2024 as part of an Antimicrobial Pipeline Session on Friday, October 18, 2024. ...See details»
Clarametyx Bioscience, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Clarametyx Bioscience, Inc. of Columbus, OH. Get the latest business insights from Dun & Bradstreet.See details»
CARB-X is funding Clarametyx Biosciences to develop an …
Nov 18, 2020 The World Health Organization (WHO) identifies these as priority bacterial threats. ... Clarametyx Biosciences is combating the formidable challenge of persistent and recalcitrant …See details»
Clarametyx Biosciences, Inc. Company Profile: Financials, Valuation ...
Clarametyx Biosciences, Inc. is a privately-held firm that develops immune-facilitated biologic therapies designed to fight life-threatening infections. Clarametyx Biosciences, Inc. was …See details»
Clarametyx Biosciences Announces Investment by Kineticos AMR ...
Clarametyx Biosciences is combating the formidable challenge of persistent and recalcitrant infections through an innovative technology platform targeting the biofilm—a protective layer …See details»
Clarametyx Biosciences - VentureRadar
The Clarametyx platform is designed to precisely remove a universal, pathogen-agnostic target within this matrix, rapidly and effectively collapsing the protective shield and sensitizing …See details»
Clarametyx Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Clarametyx Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 15 news, Disease Domain:Infectious Diseases, Technology …See details»
Clarametyx Biosciences - Contacts, Employees, Board Members, …
Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience …See details»
Clarametyx Biosciences Announces $33M Series A ... - Business Wire
Jan 5, 2024 Clarametyx Biosciences is combating the formidable challenge of persistent and recalcitrant infections through an innovative technology platform targeting the biofilm—a …See details»
Clarametyx Biosciences - zoonop.com
Oct 24, 2024 Clarametyx Biosciences is a biotechnology company based in Columbus, Ohio, focused on developing biologic therapies that target bacterial biofilms to enhance immune …See details»
Clarametyx Biosciences - Nodes Advisors
Clarametyx is a clinical-stage biotechnology company that develops immune-enabling biologic therapies to fight life-threatening infections. Their novel adjuvant therapy disrupts biofilms, a …See details»
Our Platform - Clarametyx Biosciences
CMTX-301 employs Clarametyx’ anti-DNABII technology through a vaccination approach in at-risk populations. This approach prevents the development of bacterial biofilm, enabling the body’s …See details»
Clarametyx Biosciences - Funding, Financials, Valuation & Investors
Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Clarametyx Biosciences Achieves Milestones in Investment, Clinical ...
Dec 4, 2024 Clarametyx Biosciences marked a year of impressive growth in 2024. The company’s progress highlights the potential of transformative therapies in the fight against …See details»
Investment to help develop CMTX-101 for chronic lung infections
Jan 30, 2025 “The Clarametyx scientific strategy is well aligned to our core focus on technologies and solutions to address antimicrobial resistance,” said Douglas Thomson, …See details»
Clarametyx Biosciences Launches with an Ambitious Strategy to …
COLUMBUS, Ohio – May 4, 2020 – Today marks the launch of Clarametyx Biosciences Inc., (“Clarametyx”) a preclinical stage biotechnology company developing targeted, immune …See details»
CincyTech Invests in Clarametyx to Advance Breakthrough Anti …
5 days ago Clarametyx’s lead program, CMTX-101, is being evaluated as an adjunctive therapy alongside inhaled antibiotics for people with CF suffering from chronic Pseudomonas …See details»